Information Provided By:
Fly News Breaks for February 3, 2016
PODD
Feb 3, 2016 | 08:55 EDT
Leerink analyst Danielle Antalffy says that while Insulet sold its Neighborhood Diabetes business for $58M less than it paid for the unit in 2011, the divestiture is the right move. With the sale, Insulet shed a slower-growing, lower-margin business, Antalffy tells investors in a research note. She reiterates an Outperform rating on the name with a $44 price target.
News For PODD From the Last 2 Days
There are no results for your query PODD